Michael Dale is the CEO and President of Axogen, Inc., a leading company in the field of peripheral nerve repair. With a strong background in the medical device industry, Michael has been instrumental in driving Axogen's growth and success. Before joining Axogen, he held various leadership positions at other medical device companies, including roles at ev3 and Boston Scientific. His extensive experience in the industry has equipped him with the knowledge and skills necessary to lead Axogen in its mission to improve the lives of patients with nerve injuries. As CEO and President, Michael Dale is responsible for overseeing the overall strategy and operations of Axogen. Under his leadership, the company has made significant strides in developing innovative nerve repair solutions and expanding its global presence. Michael has been a driving force behind Axogen's commitment to research and development, resulting in the introduction of several groundbreaking products that have improved patient outcomes. His vision for the company is to continue to be at the forefront of the peripheral nerve repair market, delivering high-quality products and services to healthcare professionals and patients worldwide. Michael's leadership has been recognized by the industry, with Axogen receiving numerous awards and accolades under his guidance. He has successfully navigated the company through various challenges, including the complexities of the regulatory landscape and the competitive nature of the medical device market. Michael's dedication to Axogen's mission and his ability to inspire and motivate his team have been key factors in the company's success. As CEO and President, he continues to play a pivotal role in shaping the future of peripheral nerve repair and improving the lives of patients around the world.